## Abstract Hematopoietic stem cell transplantation (HSCT) has become the standard of care for the treatment of many hematologic malignancies, chemotherapy sensitive relapsed acute leukemias or lymphomas, multiple myeloma; and for some non‐malignant diseases such as aplastic anemia and immunodefici
Stem Cell Mobilization || Quantifying Hematopoietic Stem and Progenitor Cell Mobilization
✍ Scribed by Kolonin, Mikhail G.; Simmons, Paul J.
- Book ID
- 118056352
- Publisher
- Humana Press
- Year
- 2012
- Weight
- 297 KB
- Category
- Article
- ISBN
- 1617799432
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
26.1%) patients after PR, in 9 (39.1%) after HCT and in 7 (30.4%) at the time of BM recovery. GPBB became elevated in 5 (21.7%) patients after PR, in 5 (21.7%) after HCT and remained elevated in 2 (8.7%) at the time BM recovery. CK-MB mass, cTnT, cTnI, FABP remained negative after PR and HCT in all
## Abstract High‐dose chemotherapy with autologous stem cell transplantation (ASCT) is curative treatment in various hematologic malignancies. Mobilization and collection of peripheral blood stem cell is the essential part of ASCT. The aim of this study was to evaluate the effectiveness of various